Treatment of migraine | Patent Publication Number 20220193051

US 20220193051 A1
Patent NumberUS 11717515 B2
Application Number17559177
Filled DateDec 22, 2021
Priority DateDec 22, 2020
Publication DateJun 23, 2022
Original AssigneeAbbvie Inc.
Current AssigneeAllergan Pharmaceuticals International
Inventor/ApplicantsJoel Trugman
Michelle Finnegan
Ramesh Boinpally
Abhijeet Jakate
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.